Language in a pandemic-relief bill currently before the U.S. Senate might lead to 340B ceiling prices on some branded drugs being set lower than the drugs’ average manufacturer price (AMP). | Shutterstock

Huge COVID Relief Bill That Would Lift Medicaid Rebate Caps Moves to Senate

The U.S. House on Saturday passed a $1.9 trillion COVID-19 relief bill with language that might lead to 340B ceiling prices on some branded drugs being set lower than the drugs’ average manufacturer price (AMP).

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content